title: Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient.
abstract: BACKGROUND
  A 48-year-old man with a recent diagnosis of multiple myeloma and rapidly progressive oliguric end-stage renal disease requiring hemodialysis, presented with a serum calcium concentration of 3.4 mmol/l (13.6 mg/dl).
  
  
  METHODS
  Serum laboratory analysis, electroencephalogram, MRI of the brain and bone marrow, and kidney biopsies.
  
  
  METHODS
  Hypercalcemia secondary to multiple myeloma.
  
  
  RESULTS
  Short-term intravenous disodium pamidronate therapy (30 mg daily) and daily monitoring of serum calcium concentration.
authors.affiliation: Department of Medicine, Hospital Británico de Buenos Aires, Argentina. htrimarchi@hotmail.com
authors.forename: Hernán
authors.initials: H
authors.lastname: Trimarchi
authors.forename: Fernando
authors.initials: F
authors.lastname: Lombi
authors.forename: Mariano
authors.initials: M
authors.lastname: Forrester
authors.forename: Cristina
authors.initials: C
authors.lastname: Elizondo
authors.forename: Deirdre
authors.initials: D
authors.lastname: Sawinski
authors.forename: Horacio
authors.initials: H
authors.lastname: Pereyra
authors.forename: Emilio
authors.initials: E
authors.lastname: Freixas
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000209:etiology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy; D000077268:Pamidronate; D006435:Renal Dialysis
chemical_list: D000970:Antineoplastic Agents; D004164:Diphosphonates; D000077268:Pamidronate